Fact-checked by Grok 2 weeks ago

Pulse Polio

Pulse Polio is a nationwide supplementary immunization campaign launched by the Government of India on 2 October 1994 to eradicate poliomyelitis through the mass administration of oral polio vaccine to children under five years of age. The program features intensive, synchronized national immunization days conducted multiple times annually, supplemented by house-to-house searches, transit point vaccinations, and robust surveillance for acute flaccid paralysis cases. At launch, India bore approximately 60% of global polio cases, with an estimated 150,000 annual infections driven by poor sanitation, high population density, and uneven routine immunization coverage. These efforts, coordinated with international partners like the World Health Organization and involving millions of volunteers, reduced reported cases from thousands in the 1990s to zero indigenous transmissions after 2011, culminating in WHO certification of India as polio-free in 2014. While facing obstacles including localized vaccine myths, resistance in underserved regions, and vaccine-derived poliovirus risks, the campaign exemplifies scalable public health intervention, prioritizing empirical tracking and adaptive strategies over routine systems alone.

Historical Development

Global Context of Polio Eradication

The Global Polio Eradication Initiative (GPEI) was established in 1988 through a resolution of the 41st , uniting the (WHO), , United Nations Children's Fund (UNICEF), and U.S. Centers for Disease Control and Prevention (CDC) to target the eradication of all wild (WPV) types via oral polio vaccine (OPV) campaigns. At launch, WPV caused an estimated 350,000 paralytic cases annually in more than 125 countries, with transmission sustained in areas of low routine coverage. The initiative's core strategy relied on achieving population-level immunity to block fecal-oral transmission chains, recognizing that OPV's mucosal immunogenicity provided rapid, community-wide protection superior to inactivated alternatives for outbreak control. Early efforts revealed limitations in routine schedules, which typically yielded coverage below the 80–85% threshold required to WPV circulation amid variable and . This prompted a pivot to supplementary activities (SIAs), including synchronized national and subnational days delivering two OPV doses to all children under five, designed to saturate susceptible pools and exploit OPV's short-term herd effects. Such pulsed campaigns addressed causal gaps in endemic persistence by overriding access barriers through house-to-house delivery and social mobilization, yielding verifiable declines in reported cases from over 30,000 in 1987 to under 1,500 by 1993 in monitored regions. A pivotal occurred in 1994 when the WHO certified the Region of the as free of indigenous WPV, three years after the last confirmed case in , based on sustained coverage exceeding 80% and absence of paralytic linked to wild strains. This underscored the causal efficacy of SIA-driven strategies in diverse epidemiological settings, reducing global WPV incidence by over 99% from 1988 baselines through empirically tracked rates and genomic confirming transmission interruption.

Launch and Evolution in India (1995–2011)

In the mid-1990s, India faced hyperendemic poliomyelitis transmission, with estimates of approximately 150,000 annual cases paralyzing children, accounting for over half of global incidence. To counter this, the government launched the Intensive Pulse Polio Immunisation (IPPI) program in 1995, featuring two annual National Immunization Days (NIDs) that administered two doses of trivalent oral poliovirus vaccine (tOPV) to all children under five years of age, regardless of prior immunization history. The inaugural NID on December 9, 1995, vaccinated 87.8 million children nationwide, marking a shift toward mass supplementary immunization to interrupt widespread wild poliovirus (WPV) circulation. Program scaling accelerated by 1999–2000 amid stalled progress in routine coverage, introducing sub-national immunization days (SNIDs) and more frequent rounds—up to biweekly in high-risk districts of states like and —to sustain immunity in persistent transmission zones. These efforts involved administering around 200 million tOPV doses per major national round, prioritizing underserved areas with low routine uptake and dense populations that facilitated poliovirus reservoirs. Reported WPV-associated cases began declining, from over 3,000 in 1995 to roughly 265 by 2000, though surveillance gaps and variable coverage initially limited eradication gains. Persistent WPV circulation in and , which reported the majority of cases through the early , prompted intensified mop-up campaigns from 2003 to 2005, including door-to-door searches and targeted use of monovalent OPV type 1 (mOPV1) starting in 2005 to address type-specific outbreaks. These policy-driven responses countered a 2002–2003 resurgence, with cases dropping to 225 in 2003 before a temporary uptick to 676 in 2006 due to immunity gaps in high-risk pockets. By 2010–2011, enhanced environmental surveillance, rapid case investigations, and over 200 annual SNIDs in focal areas reduced WPV incidence to isolated events, culminating in the final confirmed case on January 13, 2011, in , —WPV type 1 imported from endemic neighbors. This zero-case threshold reflected cumulative IPPI impacts, with WPV cases falling from 741 in 2000 to none by late 2011, verified through virologic testing of acute stools.

Program Implementation

Core Vaccination Strategy

The core vaccination strategy of India's Pulse Polio program centers on the mass administration of trivalent oral polio vaccine (tOPV), which protects against all three wild poliovirus serotypes. tOPV was chosen for its capacity to replicate in the , thereby inducing strong mucosal immunity that inhibits and fecal-oral transmission, a primary mode of polio spread in endemic settings with poor sanitation. Its oral delivery format enables rapid, needle-free dosing without requiring trained medical personnel for injections, making it suitable for large-scale campaigns in resource-limited areas. The program targets children aged 0–5 years, as this group bears the highest risk of from and serves as the primary for . Coverage goals emphasize vaccinating at least 95% of the target population per round to exceed the epidemiological threshold for interrupting chains of , based on models requiring near-universal immunity to prevent outbreaks given polio's reproductive number (R0) of approximately 5–7 in susceptible communities. The "" mechanism entails synchronized nationwide days, conducted 2–4 times annually, to overwhelm the through simultaneous high-dose of susceptible individuals. This approach capitalizes on polio's brief infectious period (typically 7–14 days for peak transmissibility) and serial interval, ensuring that a of new immune individuals emerges before the virus can propagate further in under-vaccinated pockets. Supplementary activities (SIAs) under Pulse Polio complement routine schedules by focusing on catch-up doses for undervaccinated children, with early rounds in the late administering doses to 75–125 million children nationwide. By the early 2000s, scale expanded to target over 165 million children per round, reflecting intensified efforts to achieve saturation immunity.

Operational Procedures and Logistics

Pulse Polio campaigns operate through a structured sequence of booth-based on designated National Immunization Days, usually Sundays, followed by house-to-house searches for missed children the subsequent day. Vaccination booths are established nationwide at accessible locations such as schools, community centers, and transit points to administer two drops of oral to eligible children aged 0-5 years. This approach ensures initial high-volume delivery while the follow-up phase targets absentees through mobile teams, with vaccinators marking vaccinated households to prevent duplication. Training constitutes a core logistical component, with comprehensive manuals prepared for frontline vaccinators, supervisors, and social mobilizers to standardize procedures, including handling, finger-marking with indelible , and reporting. Approximately 2.5 million volunteers and health workers undergo annual training to manage these large-scale efforts, focusing on micro-planning at local levels for booth setup and team deployment. Social mobilization supports operations via multi-channel awareness drives, including television and radio spots featuring celebrities on platforms like , alongside community-level door-to-door advocacy by local leaders to encourage turnout. Vaccine logistics emphasize cold-chain integrity, with oral polio transported in insulated carriers packed with frozen ice packs to remote and urban areas alike, supplemented by ice-lined refrigerators at storage points and walk-in cold rooms for bulk holding. follows a hierarchical from central warehouses to peripheral health centers, with vaccine vial monitors checked to confirm potency during transit. Campaign monitoring involves transit supervisory teams patrolling routes to oversee booth operations and team performance, complemented by independent coverage evaluation surveys that assess rates through household sampling. The inaugural national pulse in achieved over 90% coverage in most states, as verified by post-campaign surveys, demonstrating the efficacy of these procedures in scaling across India's diverse geography.

Public Health Outcomes

Decline in Wild Poliovirus Incidence

In the and early 1990s, poliomyelitis caused by wild (WPV) was hyperendemic in , with annual estimates of 200,000 to 400,000 cases based on limited extrapolating from reported paralytic incidents. The Pulse Polio program's initiation in 1995, involving nationwide supplementary activities with oral poliovirus (OPV), coincided with a marked reduction in reported WPV cases, from an estimated 50,000 in 1995 to 559–874 annually during 2006–2009 as intensified captured a shrinking burden concentrated in northern states like and . This decline accelerated after 2009, with the final confirmed WPV1 case reported on January 13, 2011, in , marking the interruption of transmission. Strain-specific eliminations underscored the program's impact on WPV diversity: WPV type 2 (WPV2), for which trivalent OPV demonstrated the highest vaccine efficacy, was the first eradicated globally, with India's last case in in October 1999 following sustained high per-capita dosing from multiple vaccination rounds. Subsequent focus on monovalent and bivalent OPV formulations targeted WPV type 1 (WPV1) and type 3 (WPV3), interrupting WPV3 chains in India by late 2010 and culminating in no WPV detections after early 2011. Genetic sequencing of isolates from acute cases and environmental samples, conducted under WHO-coordinated , confirmed the progressive fragmentation and eventual cessation of indigenous chains, with over 99% of lineages mapped and traced to exhausted local reservoirs by 2011. This virological aligned with population-level immunity thresholds achieved through repeated OPV supplementation, where average per-child doses exceeded six in high-burden areas, disrupting fecal-oral dynamics. In contrast to persistent WPV reservoirs in neighboring and —where coverage remained below 80% in conflict zones amid security disruptions—India's decline correlated with documented rises in supplementary round participation rates exceeding 95% in endemic districts by the mid-2000s, enabling the of foci despite shared borders and .

Certification and Sustained Zero Cases (2011–Present)

The World Health Organization's South-East Asia Regional Commission for the Certification of certified the region, including , as free of indigenous wild transmission on March 27, 2014, after no confirmed cases for three consecutive years following the last reported instance on January 13, 2011, in . This milestone, the fourth WHO region to achieve such status, hinged on empirical verification through intensified acute (AFP) , requiring a non-polio AFP (NPAFP) detection rate of at least two cases per 100,000 children under age 15 annually to confirm system sensitivity capable of identifying any residual or imported circulation. Sustained absence of indigenous wild poliovirus cases has persisted in India through October 2025, validated by ongoing AFP and environmental surveillance networks that exceed certification thresholds for sensitivity and timeliness. Maintenance efforts include periodic Pulse Polio rounds, such as the October 2025 special drive in Telangana—including Hyderabad—which administered oral polio vaccine to over 1.7 million children aged 0–5 across six districts to mitigate risks of reintroduction or vaccine-derived strains. Despite this, global vigilance against circulating vaccine-derived poliovirus (cVDPV) remains essential, as 2024 saw 280 confirmed cVDPV cases across multiple countries, underscoring the need for India's high-coverage model to counter outbreaks in under-immunized areas. India's certification process and subsequent zero-case maintenance have shaped the Global Polio Eradication Initiative by demonstrating scalable strategies for dense populations, including adaptive vaccination logistics and that informed risk assessments in remaining endemic zones. However, empirical highlight ongoing challenges, as cVDPV emergence—linked to low routine in some regions—necessitates sustained supplementary campaigns to prevent reversal of gains, with India's contributing to outbreak modeling.

Challenges in Execution

Logistical and Infrastructural Hurdles

In high-burden states like , logistical hurdles included limited access to remote rural areas characterized by poor road infrastructure, high , and seasonal , which collectively impeded consistent coverage during national immunization days. These factors exacerbated challenges in tracking and reaching mobile populations, such as those in brick kilns and urban slums, leading to initial gaps in campaign reach estimated at 10-20% in underserved pockets during early rounds. flooding further disrupted operations by inundating pathways and hampering vaccinators' mobility in flood-prone regions. Supply chain vulnerabilities, particularly cold chain maintenance, posed additional risks, with frequent power outages and high ambient temperatures in rural districts threatening viability during transport and storage. Assessments during pulse polio national days revealed inconsistencies in vaccine carrier temperatures, underscoring the need for robust monitoring to prevent exposure to suboptimal conditions. These barriers were progressively addressed through intensified micro-planning at the and village levels, which involved detailed of habitations, , and supervisor oversight to enhance operational precision. Incorporation of (GIS) tools aided in visualizing inaccessible terrains and optimizing team routes, contributing to verifiable gains in coverage—from approximately 77% for dual doses in early urban pilots like in 1995-1996 to over 95% in national rounds by 2010. Such strategies enabled scaling to nearly 700,000 booths and 1.2 million vaccinators per campaign, minimizing logistical shortfalls in high-risk areas.

Community and Political Factors

Vaccine hesitancy in certain communities, particularly Muslim-majority areas in northern , stemmed from alleging that oral caused sterility or , often linked to of government programs influenced by historical campaigns. Such fears contributed to localized refusals during Pulse Polio rounds, exacerbating challenges in high-risk districts of where circulation persisted into the early 2000s. Repeated vaccination campaigns led to community fatigue, with parents citing inconvenience and skepticism over necessity after multiple doses, though surveys reported reasons like safety concerns in only 5.7% of non-compliant households and sterility fears in 1.9%. In , resistance manifested as refusals tied to internal community dynamics and unmet health needs, prompting strategies involving local leaders to address fears and improve acceptance. Political endorsements enhanced program buy-in; issued national appeals for participation, such as in December 2001, and personally administered doses during events like the February 2004 Pulse Polio Day in , signaling high-level commitment that facilitated scale-up. NGO involvement and celebrity support boosted turnout; Amitabh Bachchan's role as from 2002, through campaigns like "Do Boond Zindagi Ki," raised awareness and countered hesitancy, coinciding with a decline in cases from 1,556 in 2002. Coverage evaluations revealed urban-rural disparities, with a Chandigarh survey showing 98.4% coverage in rural areas versus 89.8% in urban and 93% in slums, underscoring needs for tailored mobilization in densely populated or migratory settings. Overall, civil society engagement helped mitigate resistance, achieving high participation rates despite persistent pockets of skepticism.

Controversies and Adverse Events

Rise in Non-Polio Acute Flaccid Paralysis (NPAFP) Rates

Non-polio acute (NPAFP) encompasses cases of acute in children under 15 years or individuals of any age with suspected poliomyelitis and residual paralysis lasting over 60 days, excluding evident non-infectious etiologies such as ; requires two stool samples testing negative for wild . This metric functions as a for AFP surveillance adequacy in polio eradication certification, where the stipulates a minimum annualized rate of at least 2 NPAFP cases per 100,000 children under 15 years to confirm sufficient system sensitivity for detecting any circulation. In , NPAFP rates remained below 1 per 100,000 children under 15 prior to the 1995 initiation of intensified Pulse Polio , with early post-launch data recording just 0.22 per 100,000 in 1997 amid nascent network expansion. By 2004, rates had climbed to 3.11 per 100,000, escalating further to 12 per 100,000 in 2010 and peaking at 13.35 per 100,000 in 2011—substantially surpassing WHO thresholds and reflecting heightened detection capabilities. The 2011 apex documented approximately 47,500 excess NPAFP cases beyond anticipated baseline levels (at 2 per 100,000), coinciding with India's final wild poliovirus detection on January 13. These incidents mimic poliomyelitis clinically, featuring rapid-onset often without , alongside elevated regional mortality—such as 8.5% in at 60-day follow-up, reportedly up to twice that of wild polio cases—and substantial residual deficits in 35% of survivors. While NPAFP stool specimens uniformly lack wild , virologic analysis reveals associations with non-polio enteroviruses or polioviruses in portions of cases. Indian National Polio Surveillance Project and WHO datasets illustrate a pronounced inverse trend with wild occurrences, wherein NPAFP escalation correlates with rigorous case hunting, stool collection mandates (two samples within 14 days from 95%+ of cases), and subnational reporting enhancements, unmasking previously underreported paralytic events.

Correlations with Pulse Frequency and Vaccine-Associated Risks

Analysis of non-polio acute (NPAFP) data from 2000 to 2010 revealed a positive between the number of oral (OPV) pulse rounds conducted in states and the corresponding NPAFP rates, with coefficients exceeding 0.7 when considering state-specific . This association strengthened when accounting for cumulative OPV doses administered over preceding years, yielding an R² of 32.1% (p < 0.001), suggesting that higher frequency contributed to elevated reporting beyond baseline expectations. Nationally, NPAFP cases rose from approximately 7,260 in 2000 to over 59,000 by 2012, paralleling the escalation in supplemental immunization activities during peak years. The inherent risk of vaccine-associated paralytic poliomyelitis (VAPP) from OPV is estimated at 1 case per 2.4 million doses distributed, with higher incidence following the first dose (approximately 1 per 750,000). In India's Pulse Polio context, children in high-risk areas often received 20 or more supplemental OPV doses over their early years, potentially magnifying aggregate VAPP occurrences; empirical modeling from campaign data indicated excess paralysis cases numbering in the hundreds of thousands, aligned with pulse frequency rather than wild poliovirus resurgence. Following certification of polio-free status in 2014, reductions in pulse rounds—from up to 5-6 annually to fewer—correlated with declining NPAFP rates (R = 0.46; p < 0.001), dropping from 13.35 per 100,000 children in 2011 to levels approaching the global baseline of 1-2 per 100,000 by 2017, prompting proposals for further de-escalation to minimize unintended risks. Official interpretations, including those from the Indian Ministry of Health and WHO, attribute these NPAFP trends primarily to intensified rather than causation, emphasizing that enhanced case detection explains the rise during eradication efforts. In contrast, independent analyses by researchers such as Jacob Puliyel argue for underrecognized -induced harm, citing the temporal alignment with OPV dosing and post-reduction declines as evidence of de-challenge effects, though they acknowledge residual diagnostic uncertainties in attributing individual cases. These divergent views highlight ongoing debates over whether observed excesses represent collateral VAPP or artifacts of reporting improvements, with peer-reviewed data underscoring the need for rigorous dose-response scrutiny in high-intensity campaigns.

Debates on Causation and Program Overreach

Critics of the Pulse Polio program, including pediatrician Jacob Puliyel, have argued that the elevated rates of non-polio acute flaccid paralysis (NPAFP) observed in India serve as a proxy for vaccine-associated paralytic polio (VAPP), attributing causation to excessive oral poliovirus vaccine (OPV) dosing through repeated pulse campaigns. Puliyel and colleagues analyzed national surveillance data from 2011 to 2017, finding a direct correlation between NPAFP incidence and the frequency of pulse polio rounds per state, with NPAFP rates declining after rounds were reduced from two to one annually starting in 2016, suggesting a dose-response relationship indicative of OPV-induced harm rather than unrelated etiologies. They contend this reflects net harm from over-immunization in a low-prevalence setting, where the risks of VAPP—estimated globally at 2-4 cases per million OPV doses—accumulate without proportional benefits after wild poliovirus transmission ceased. Proponents, including officials from the (WHO) and India's Ministry of Health, counter that heightened NPAFP reporting stems from enhanced surveillance sensitivity rather than vaccine causation, as India's NPAFP rate exceeding the WHO benchmark of 2 per 100,000 children under 15 demonstrates robust case detection rather than excess paralysis. They maintain that while OPV carries inherent VAPP risks, the program's pulses were justified by the precipitous decline in wild poliovirus cases from thousands annually pre-2000 to zero since January 2011, with residual campaigns preventing resurgence amid imperfect routine immunization coverage. Empirical models support this by projecting that sustained OPV use averts more paralytic cases long-term than isolated VAPP incidents, given OPV's superior mucosal immunity for interrupting fecal-oral transmission compared to inactivated (IPV). Debates on program overreach center on whether continued mass OPV pulses post-2011 constituted unnecessary risk escalation, with Puliyel advocating an immediate declaration of victory and transition to IPV to eliminate VAPP while preserving . OPV's affordability—approximately $0.10-0.18 per dose—facilitated India's scale-up, enabling billions of administrations at low , whereas IPV's higher price ($0.90-2.00 per dose) and injection requirements pose logistical and economic barriers in resource-constrained settings. However, causal assessments highlight OPV's trade-offs: its live-virus replication induces herd-level gut immunity critical for outbreak containment but risks circulating vaccine-derived polioviruses (cVDPVs) in under-vaccinated pockets, prompting WHO recommendations for synchronized global OPV cessation and IPV introduction to balance safety against resurgence threats. Critics question the empirical for "overreach," noting that India's NPAFP burden—potentially masking VAPP—may exceed averted wild cases, urging first-principles reevaluation of dose intensity based on verifiable transmission dynamics rather than precautionary excess.

Post-Eradication Phase

Ongoing Surveillance and Campaigns (2014–2025)

Following certification of wild poliovirus-free status in 2014, has sustained Pulse Polio campaigns through 1–2 annual National Immunization Days (NIDs) or Sub-National Immunization Days (SNIDs), administering oral polio vaccine to children aged 0–5 years to preserve buffers against reintroduction risks. These reduced-frequency drives, integrated with routine , have vaccinated millions periodically; for instance, in 2025, NIDs were held on February 16 targeting 0–6-year-olds and October 12 focusing on 0–5-year-olds, with booth follow-ups on subsequent days in high-risk areas like migrant camps. ![Pulse Polio Day, Gwalior, January 2014][float-right] World Polio Day observances on October 24, 2025, highlighted the need for sustained participation in these campaigns, underscoring empirical evidence that high coverage prevents silent circulation despite global persistence of the virus. Environmental surveillance, involving sewage sampling from over 100 sites nationwide, continues to detect trace vaccine-derived poliovirus (VDPV) shedding, such as type-1 VDPV in sewage in April 2022, enabling rapid outbreak investigations and targeted mop-up vaccinations without escalation to cases. This system, alongside acute flaccid paralysis (AFP) reporting with stool testing, integrates with the Universal Programme to monitor for any circulation, maintaining sensitivity through laboratory networks despite planned phased reductions in the National Polio Surveillance Network starting June 2025. India has recorded zero wild poliovirus detections or importation events post-2011, corroborated by consistent negative AFP and environmental results, affirming effective containment amid neighboring endemic transmission. Globally, 15 wild poliovirus type-1 (WPV1) cases were reported as of early August 2025—14 in and 1 in —necessitating vigilant border screening and cross-border coordination to avert import risks.

Transitions to Routine Immunization and IPV

Following the global certification of wild poliovirus type 2 and 3 eradication, a synchronized switch from trivalent oral polio vaccine (tOPV) to bivalent OPV (bOPV) was implemented worldwide between April 17 and May 1, 2016, in 155 countries to withdraw type 2 OPV and curb risks from circulating vaccine-derived poliovirus type 2 (cVDPV2). This transition aligned with the Polio Eradication and Endgame Strategic Plan, emphasizing the introduction of at least one dose of inactivated poliovirus vaccine (IPV) into routine immunization schedules to maintain humoral immunity against type 2 poliovirus while relying on bOPV for types 1 and 3. In , IPV was incorporated into the Universal Programme (UIP) starting November 2015, initially as a single dose at 14 weeks alongside existing OPV doses, to provide risk mitigation ahead of the tOPV withdrawal. This marked a shift toward integrating protection into routine schedules, reducing dependence on mass pulse campaigns, with UIP enhancements post-2014 expanding the vaccine basket to include IPV among six new antigens for sustained coverage without recurrent supplementary activities. However, IPV scale-up encountered logistical barriers, including the need for injection-trained health workers, sterile syringes, and enhanced capacity for fractional dosing in resource-limited settings, alongside higher procurement costs relative to OPV. Routine immunization gaps persisted, with diphtheria-tetanus-pertussis third dose (DTP3) coverage—a for overall UIP performance—falling below 90% in states like and as of 2021-2023 estimates, reflecting uneven and hesitancy that hybrid models seek to address through routine IPV priming supplemented by bOPV boosts for mucosal immunity. These approaches prioritize empirical maintenance of population immunity thresholds above 80-90% to prevent resurgence, informed by post-switch showing stable zero wild poliovirus cases but ongoing VDPV monitoring.

Empirical Assessments

Data-Driven Evaluations of Efficacy and Costs

The Pulse Polio programme, launched in 1995, is estimated to have averted approximately 3.94 million paralytic polio cases in India through intensive oral polio vaccine (OPV) campaigns, alongside preventing 393,918 deaths and 1.48 billion disability-adjusted life years (DALYs). These gains stem from reducing annual polio incidence from an estimated 150,000–200,000 cases in the mid-1990s to zero wild poliovirus (WPV) cases after January 2011. Economic benefits from averted disability and productivity losses are projected at $1.71 trillion (in 2013 USD), reflecting substantial returns from preventing lifelong impairments such as paralysis, which historically imposed high societal costs through medical care and lost wages. Total direct costs for India's polio elimination efforts, including Pulse Polio rounds, approached $2 billion from government expenditures between 1995 and 2014, with per- costs during supplementary campaigns ranging from $1.80 for routine elements to higher figures for intensified pulses due to like volunteer mobilization and temporary suspension of other services. A single round of intensified Pulse Polio at primary health centers incurred direct costs of about Rs 24.2 per vaccinated (approximately $0.50 in 2009 USD) and consumed 4,446 person-hours across , diverting resources from routine . This yields a favorable cost-benefit ratio, with net economic returns exceeding program outlays by orders of magnitude, primarily through DALY savings valued at standard metrics (e.g., $1,000–$5,000 per DALY in low-income contexts). However, burdens include vaccine-associated paralytic poliomyelitis (VAPP), with risks estimated at 1 case per 2.8–4.6 million OPV doses administered, particularly higher for first-dose recipients (1 per 2.8 million). In 1999, India reported 181 VAPP cases among children under five, and pre-bivalent OPV switch (around 2016), trivalent OPV contributed to roughly 200 annual VAPP instances linked to type 2 poliovirus. Over the program's lifespan, involving billions of doses across birth cohorts of 20–25 million annually, this translates to thousands of VAPP cases, each imposing similar disability burdens to wild polio but without transmission risk. Post-2011, after WPV elimination, empirical assessments highlight diminishing marginal returns from repeated high-frequency pulses, as incremental case aversion declined amid low endemic risk, while sustaining VAPP incidence and opportunity costs for alternative interventions like routine vaccinations for measles or diarrhea. Overall, while WPV eradication justifies core investments, the program's total efficacy must account for these iatrogenic outcomes and resource trade-offs in a resource-constrained setting.

Criticisms of Surveillance Metrics and Long-Term Impacts

Critics have argued that targets for non-polio acute (NPAFP) in India's may encourage over-reporting to meet WHO benchmarks of at least two cases per 100,000 children under 15 years, leading to inflated rates that reached 13.35 per 100,000 in , far exceeding expectations. This surge correlated with increased pulse polio rounds, with studies observing sharp NPAFP rises after more than six annual doses of oral (OPV), potentially misattributing paralysis cases unrelated to wild . Such metrics, while endorsed by official bodies like the WHO for certifying polio-free status, have prompted concerns over diagnostic accuracy, as NPAFP investigations often classify diverse etiologies under a broad umbrella without granular causation analysis. Long-term OPV exposure under the Pulse Polio regimen carries risks of vaccine-associated paralytic poliomyelitis (VAPP) and immunodeficiency-associated vaccine-derived polioviruses (iVDPV), particularly in immunocompromised individuals who may shed mutated strains for years, undermining eradication sustainability. VAPP cases, estimated at 2-4 per million doses, are not officially tallied as polio by Indian authorities on grounds of sporadic occurrence, potentially undercounting vaccine-induced paralysis amid cumulative dosing from repeated campaigns. Empirical gaps persist in quantifying these, with calls from medical ethicists for distinguishing vaccine harms from wild-type disease to avoid conflating program success with suppressed reporting. Sustained NPAFP burdens have shown higher lethality than historical polio cases, with fatality rates twice as elevated in some analyses, raising questions about misattribution and unaddressed enteroviral or al triggers overlooked in OPV-focused . Resource allocation toward intensive pulse campaigns has been critiqued for diverting personnel and infrastructure from routine , exacerbating coverage gaps in other during peak polio drives. Independent audits have been advocated by bodies like the to scrutinize these metrics against official endorsements, highlighting tensions between certification imperatives and transparent risk assessment.

References

  1. [1]
    INDIA: A push to vaccinate every child, everywhere, ended polio in ...
    Apr 7, 2021 · India rolled out the Pulse Polio Immunization Programme on 2 October 1994, when the country accounted for around 60% of the global polio cases.
  2. [2]
    Eradicating poliomyelitis: India's journey from hyperendemic to polio ...
    During the years since 2004 annual pulse polio vaccination campaigns were conducted 10 times each year, virtually every child was tracked and vaccinated - ...
  3. [3]
    [PDF] Pulse Polio Programme in India
    Jan 13, 2011 · India committed to the resolution passed by World Health Assembly for global polio eradication in 1988. • Country introduced polio vaccine ...
  4. [4]
    [PDF] INDIA POLIO FACT SHEET
    Jan 13, 2012 · When the Pulse Polio Immunisation Programme was launched in India in 1995 an estimated 150,000 polio cases were reported across the country ...<|control11|><|separator|>
  5. [5]
    A study of the knowledge and attitude towards pulse polio ...
    This study identified a few important misconceptions associated with polio and PPI which need to be addressed by large scale awareness campaigns in order to ...
  6. [6]
    Who we are - GPEI
    Launched in 1988 after the World Health Assembly passed a resolution to eradicate polio, the Global Polio Eradication Initiative, along with its partners, has ...
  7. [7]
    Poliomyelitis - World Health Organization (WHO)
    Apr 2, 2025 · Wild poliovirus cases have decreased by over 99% since 1988, from an estimated 350 000 cases in more than 125 endemic countries then, to two ...
  8. [8]
    Supplementary Immunization - GPEI
    The aim of mass campaigns is to interrupt circulation of poliovirus by immunizing every child under five years of age with two doses of oral polio vaccine.
  9. [9]
    Coronavirus disease (COVID-19): Herd immunity, lockdowns and ...
    For polio, the threshold is about 80%. The proportion of the population that must be vaccinated against COVID-19 to begin inducing herd immunity is not known.
  10. [10]
    Worldwide status of poliomyelitis in 1986, 1987 and 1988, and plans ...
    In 1986, a total of 28,951 cases of poliomyelitis were reported to WHO by 175 countries/areas. For 1987, 35,685 cases were reported by 168 countries/areas.<|separator|>
  11. [11]
    Progress Toward Global Eradication of Poliomyelitis, 1988-1993
    From 1988 through 1993, reported cases of polio decreased from 4546 to 1437. ... In 1993, nearly two thirds of all polio cases reported worldwide were from ...
  12. [12]
    International Notes Certification of Poliomyelitis Eradication - CDC
    The ICCPE required three criteria before the Region of the Americas could be certified as polio-free: 1) high (i.e., more than 80%) levels of vaccination ...
  13. [13]
    Polio Eradication in India: Myth or Reality - ScienceDirect
    Intensive Pulse Polio Immunisation (IPPI) was started in 1995, when all children under five years of age, irrespective of their immunisation status, were given ...<|separator|>
  14. [14]
    Progress Toward Poliomyelitis Eradication -- India, December 1995 ...
    On December 9, 1995, the government of India conducted the first round of PPIDs, vaccinating 87.8 million children with one dose of OPV. Of the children ...
  15. [15]
    Indian Pediatrics - Editorial
    In 1995 Government of India launched the Pulse Polio Immunization (PPI) for the eradication of poliomyelitis. In 1999, a vastly intensified pulse polio ...
  16. [16]
    Government
    The first such sub-national immunisation will be conducted on September 24 in UP, Bihar, West Bengal and Delhi, where widespread transmission of polio virus was ...<|separator|>
  17. [17]
    Progress Toward Poliomyelitis Eradication --- India, January 2005
    Jul 21, 2006 · SIAs added mOPV1 in April 2005, and it was used in most SIA rounds conducted during April--November in Bihar, UP, Mumbai (Maharashtra state), ...Missing: Pulse mop- 2003-2005
  18. [18]
    India launches largest ever campaign to tackle polio epidemic
    Feb 5, 2003 · The campaign, the second of 2003, is to combat a growing polio epidemic that swept the northern part of the country last year. In 2002, the ...Missing: Pulse mop- Bihar 2003-2005
  19. [19]
    Polio Eradication in India: Myth or Reality - PMC - PubMed Central
    The 225 cases reported in 2003 are the lowest number of polio cases in India's history with Uttar Pradesh and Bihar reporting the lowest number of cases ever. ...
  20. [20]
    India without Poliomyelitis: Time to Make it a Reality - PMC
    In the year 2005, India reported 66 cases of polio. However, in 2006, the cases of wild polio virus increased to 676. This rise in cases in 2006 was expected ...
  21. [21]
    Zero Case: India's Polio Eradication Saga
    Nov 19, 2024 · Pulse Polio Programme Launch (1995)​​ India's fight against polio took a significant step forward in 1995 with the launch of the Pulse Polio ...
  22. [22]
    Progress Toward Poliomyelitis Eradication --- India, January 2010
    Nov 4, 2011 · Until 2010, most polio cases in India were reported in Uttar Pradesh and Bihar, two states with low routine vaccination coverage, lower vaccine ...<|control11|><|separator|>
  23. [23]
    Oral polio vaccine - GPEI
    The oral polio vaccine (OPV) is safe and extremely effective, and the most common kind of vaccine used in the fight to eradicate polio.
  24. [24]
    Mucosal immunity to poliovirus - PMC - PubMed Central - NIH
    Jul 8, 2021 · Oral polio vaccine (OPV) replicates extensively in the gastrointestinal tract and is distinguished by its ability to induce intestinal immunity, ...
  25. [25]
    Pulse Polio Programme | Health - Vikaspedia
    The Pulse Polio Initiative was started with an objective of achieving hundred per cent coverage under Oral Polio Vaccine. It aimed to immunize children through ...
  26. [26]
    [PDF] A Trainers Manual for Front-line Workers
    This manual guides trainers to train front-line workers on polio, communication skills, and to engage with families to get children vaccinated.
  27. [27]
    Pulse Polio Immunisation Vaccinator Training Module 2005 April
    Rating 5.0 (5) The document provides guidance for training vaccinators for polio vaccination activities in India. It covers: 1. Ensuring all vaccinators and supervisors ...
  28. [28]
    [PDF] Training Manual - Global Polio Eradication Initiative
    Vaccination is the only protection against polio. 5. Oral Polio Vaccine is one of the safest and most effective vaccines in history. 6. In every culture parents ...
  29. [29]
    Update on Vaccination Campaign for Children | GOI
    Aug 1, 2025 · IEC dissemination is carried out through service broadcasters such as Doordarshan using media celebrities, radio jingles and YouTube podcasts.
  30. [30]
    Evaluation of the Cold-Chain for Oral Polio Vaccine in a Rural ...
    Study of operational aspects of pulse polio booths during Intensified Pulse Polio Immunization Campaign in assembly segments of East Delhi. J Commun Dis ...Missing: procedures | Show results with:procedures
  31. [31]
    [PDF] cold chain logistics and vaccine management during polio ...
    A global standard operating procedure for vaccine management (SOP-VM) to report on vaccine utilization has been designed. (Annex 2). The May 2015 report of the.
  32. [32]
    Assessment of cold-chain maintenance in vaccine carriers during ...
    Oral polio vaccine is heat sensitive and requires maintenance of a stringent cold chain. Therefore, vaccine carriers with ice packs are used in the Pulse Polio ...Missing: logistics transport
  33. [33]
    The CORE Group Polio Project: An Overview of Its History and ... - NIH
    By 1999, high levels of polio immunization coverage had led to the ... monitoring to measure the quality of coverage during campaigns. To stop polio ...
  34. [34]
    Pulse Polio Immunization India | PDF - Scribd
    India should be polio -free by 2005. Outcomes q. PPI coverage surveys show over 99% of target children reached. 19 NIDs and 12 SNIDs conducted during 1995 ...<|separator|>
  35. [35]
    Progress Toward Poliomyelitis Eradication --- India, January 2007
    Jul 10, 2009 · The last cases of WPV type 2 worldwide were reported in October 1999 in India (1). However, transmission of WPV type 1 (WPV1) and WPV type 3 ...
  36. [36]
    India records one year without polio cases
    Jan 12, 2012 · India appears to have interrupted wild poliovirus transmission, completing one year without polio since its last case, in a 2-year-old girl ...Missing: 1988-2011 | Show results with:1988-2011
  37. [37]
    role of genetic sequencing and analysis in the polio eradication ...
    May 20, 2020 · Genetic sequencing of polioviruses detected through clinical and environmental surveillance is used to confirm detection, identify their likely origin.
  38. [38]
    WHO South-East Asia Region certified polio-free
    Mar 27, 2014 · This is the fourth of six WHO Regions to be certified, marking an important step towards global polio eradication.
  39. [39]
    WHO SOUTH-EAST ASIA REGION DECLARED POLIO-FREE - GPEI
    Mar 27, 2014 · WHO South-East Asia Region, home to a quarter of the world's population, was certified polio-free today by an independent commission, ...
  40. [40]
    Surveillance To Track Progress Toward Polio Eradication - CDC
    Apr 4, 2024 · The threshold of two or more NPAFP cases indicating that AFP surveillance is sufficiently sensitive to detect circulating polio is based on a ...<|separator|>
  41. [41]
    Evaluating Surveillance Indicators Supporting the Global Polio ...
    Apr 12, 2013 · AFP Surveillance​​ Countries in WHO regions certified as polio-free* should achieve an annual NPAFP rate of ≥1 case per 100,000 population aged < ...
  42. [42]
    Zero Case India Polio Eradication Saga
    Mar 12, 2024 · In 2011, India saw the last case of wild poliovirus in Howrah, West Bengal. Following that, the country ramped up its surveillance efforts, and ...
  43. [43]
    Telangana steps up pulse polio drive: 16.35 lakh children covered ...
    Oct 12, 2025 · Telangana steps up pulse polio drive: 16.35 lakh children covered on Day 1. Updated - October 12, 2025 09:26 pm IST - HYDERABAD. Siddharth Kumar ...
  44. [44]
    Pulse Polio Drive Begins in Hyderabad, Targeting Over 5 Lakh ...
    Oct 12, 2025 · Hyderabad is among six districts in Telangana where the special drive is being conducted from October 12 to 15. At the Urban Primary Health ...
  45. [45]
    Statement of the forty-first meeting of the Polio IHR Emergency ...
    Apr 10, 2025 · In 2024, there have been 280 cVDPV cases, of which 265 are cVDPV2, 11 cVDPV1 and four are cVDPV3. Additionally, 257 environmental samples were ...
  46. [46]
    India's Polio Eradication: A Doctor's Journey and Lessons
    Oct 13, 2022 · Polio cases worldwide have dropped by 99.9% since 1988, when the Global Polio Eradication Initiative (GPEI) began, and wild polio now remains endemic in only ...
  47. [47]
    Vaccine Derived Poliovirus count - GPEI
    Global circulating vaccine-derived (cVDPV). AFP cases and environmental samples 2021 - 2025. Press Enter to explore data. Press Enter to explore data.
  48. [48]
    Successful polio eradication in Uttar Pradesh, India: the pivotal ...
    Mar 1, 2013 · In the mid-1990s, an estimated 150,000 polio cases were reported annually in India. By 2012, polio had been eradicated in the country. Millions ...
  49. [49]
    Outcomes of polio eradication activities in Uttar Pradesh, India
    The primary strategy to interrupt transmission of wild poliovirus in India is to improve supplemental immunization activities and routine immunization ...
  50. [50]
    Assessment of cold-chain maintenance in vaccine carriers during ...
    Assessment of cold-chain maintenance in vaccine carriers during Pulse Polio National Immunization Day in a rural block of India · View/Open · View Statistics.
  51. [51]
    Pulse polio immunization in Delhi--1995-96: a survey - PubMed
    Six-hundred-and-nine children of under-3 age group were covered in the survey. Overall coverage for both the doses was found to be 77%. While coverage for 9th ...
  52. [52]
    India records sharp decline in polio cases - Deccan Herald
    Oct 23, 2010 · This resulted in significant increase in coverage to over 95 per cent during 1990-91 and is being sustained over 90 per cent since then.The ...<|separator|>
  53. [53]
    An Investigation of the Polio Disparity Affecting Muslims during ...
    Distrust of the government and resistance to vaccination were linked to this disparate development and fears of sterilization influenced by the "Family Planning ...Missing: hesitancy | Show results with:hesitancy
  54. [54]
    Growing fear about vaccination (including in India) is bringing back ...
    Mar 30, 2019 · Major rumors included suggestions that the polio vaccine caused infertility/impotency, especially among Muslim boys and that vaccination ...
  55. [55]
    Underserved and Overdosed? Muslims and the Pulse Polio Initiative ...
    Aug 6, 2025 · Most prominent was the Pulse Polio campaign, launched in 1995-a public health intervention where Muslims were described to be at the 'sharp end' ...Missing: sterility | Show results with:sterility
  56. [56]
    Community Perception Toward Intensified Pulse Polio Immuniza...
    India's fight against polio began in the backdrop of an estimated 2 lakhs cases of polio paralysis every year, and in 1995 intensified pulse polio ...Missing: numbers pre-<|separator|>
  57. [57]
    Reducing resistance against polio drops | Request PDF
    Aug 10, 2025 · Overall, the community's hesitancy to accept polio was fueled by genuine fear, internal rivalries and unattended health problems, such as ...<|separator|>
  58. [58]
    pm's appeal to make pulse polio campaign a resounding success
    The Prime Minister, Shri Atal Bihari Vajpayee made an appeal to the nation to make the Pulse Polio campaign a resounding success. The campaign will be ...
  59. [59]
    File:The Prime Minister Shri Atal Bihari Vajpayee administering the ...
    Aug 10, 2018 · The Prime Minister Shri Atal Bihari Vajpayee administering the Polio Drops to a child during the " Pulse Polio Day " in Lucknow on February 22, ...
  60. [60]
    When Amitabh's voice did the trick to make India polio free - The Hindu
    Jul 28, 2014 · When polio cases peaked in India in 2002, with 1,556 cases being detected, Amitabh Bachchan was made brand ambassador for the Polio ...
  61. [61]
    #WorldPolioDay: How Amitabh Bachchan drove India to become ...
    Oct 24, 2017 · ... Polio Eradication Campaign in 2002. Aishwarya Rai and Amitabh Bachchan in a still from a Pulse Polio advertisement. Picture courtesy ...
  62. [62]
    coverage evaluation survey of pulse polio immunization in chandigarh
    PPI coverage for rural, urban and slum areas was 98.4%, 89.8% and 93% respectively.
  63. [63]
    Involvement of Civil Society in India's Polio Eradication Program - NIH
    In March 2014, India was declared polio-free, along with the entire Southeast Asian region, and the whole country cheered the historic and notable culmination ...
  64. [64]
    Correlation between Non-Polio Acute Flaccid Paralysis Rates ... - NIH
    Aug 15, 2018 · The last case of polio from India was reported in 2011. That year, the non-polio acute flaccid paralysis (NPAFP) rate in India was 13.35/100,000 ...
  65. [65]
    Surveillance to Track Progress Toward Polio Eradication - CDC
    Apr 13, 2018 · The first is the nonpolio AFP (NPAFP) rate (i.e., the number of NPAFP cases per 100,000 children aged <15 years per year); an NPAFP rate ≥2 ...Missing: criteria minimum<|separator|>
  66. [66]
    (PDF) Poliomyelitis surveillance: The model used in India for polio ...
    Aug 9, 2025 · The number of polio cases associated with the isolation of wild poliovirus decreased from 211 in the first quarter of 1998 to 77 in the first ...Missing: biweekly | Show results with:biweekly
  67. [67]
    Trends In Non-polio Acute Flaccid Paralysis Incidence In India
    NPAFP increased with the OPV doses used. (R2=32.1%;P&lt;0.001). Correlation was best when cumulative dose received over the previous 4 years was considered (R2 ...
  68. [68]
    Trends in Nonpolio Acute Flaccid Paralysis Incidence in India 2000 ...
    Feb 1, 2015 · NPAFP increased with the number of oral polio vaccine (OPV) doses used (R2 = 25.02%; P < .001). When effect of cumulative doses over the ...
  69. [69]
    Frequency of polio vaccination linked to paralysis: study
    Sep 6, 2018 · The number of cases of non-polio acute flaccid paralysis increased from 7260 in 2000 to 59462 in 2012, says a study.
  70. [70]
    Poliomyelitis Prevention in the United States: Introduction of A ... - CDC
    Although the risk for VAPP is low (approximately one case to 2.4 million doses distributed, or one case to 750,000 children receiving their first dose of OPV) ...
  71. [71]
    But 40,000+ cases of AFP in India must mean polio is thriving, right ...
    Mar 28, 2019 · A total of 59,436 AFP cases were investigated in India in 2012, another 53,421 in 2013 and 53,383 in 2014. Not a single AFP case has tested ...Missing: peak | Show results with:peak
  72. [72]
    Correlation between Non-Polio Acute Flaccid Paralysis Rates with ...
    Aug 15, 2018 · NPAFP rate correlated with the OPV pulse polio rounds in that year (R = 0.46; p < 0.001), and the NPAFP rate started to decrease from 2012 when ...Missing: coverage | Show results with:coverage
  73. [73]
    (PDF) Correlation between Non-Polio Acute Flaccid Paralysis Rates ...
    NPAFP rate correlated with the OPV pulse polio rounds in that year (R = 0.46; p < 0.001), and the NPAFP rate started to decrease from 2012 when the number of ...Missing: synchronized | Show results with:synchronized
  74. [74]
    Correlation between Non-Polio Acute Flaccid Paralysis Rates with ...
    From the results, the NPAFP rate has been shown to decline with a reduction in the pulse polio doses. This response to de-challenging adds weight to the ...
  75. [75]
    Polio programme: let us declare victory and move on | Jacob M Puliyel
    Clinically indistinguishable from polio paralysis but twice as deadly, the incidence of NPAFP was directly proportional to doses of oral polio received. Through ...
  76. [76]
    Projection of Costs of Polio Eradication Compared to Permanent ...
    Conclusions. Overall, we find that eradication of polio would likely be cost-saving compared to permanent control. Significant uncertainty exists around the ...
  77. [77]
    [PDF] Economic analysis of the global polio eradication initiative
    Cost-effectiveness ratios for the GPEI vs. only routine vacci- nation qualify as highly cost-effective based on standard criteria. We estimate incremental ...Missing: efficacy | Show results with:efficacy
  78. [78]
    Trade-offs of different poliovirus vaccine options for outbreak ... - NIH
    Jan 12, 2024 · Adding IPV use to OPV response compared to OPV alone only marginally effective and not cost-effective. 2017 [50], Global, IPV response with OPV ...
  79. [79]
    Press Releases | Ministry of Health and Family Welfare | GOI
    Jun 28, 2025 · Pulse Polio Campaigns: Through National Immunization Days (NIDs) and Sub-National Immunization Days (SNIDs), India has maintained polio-free ...
  80. [80]
    Polio Immunization Day on 16th February 2025 - Pujali Municipality
    Feb 17, 2025 · On February 16, 2025, we conducted a Polio Immunization Day targeting children aged 0 to 6 years. This initiative is part of the ongoing efforts to maintain ...<|separator|>
  81. [81]
    The Pulse Polio Programme will be held on 12th October 2025. All ...
    Oct 8, 2025 · The Pulse Polio Programme will be held on 12th October 2025. All children aged 0–5 years must receive the Polio vaccine.
  82. [82]
    https://www.ndtv.com/health/world-polio-day-2025-a-reminder-to-protect-every-child-in-polio-free-india-9502137
  83. [83]
    Investigation of the vaccine-derived polio virus found in sewage ...
    Jun 17, 2022 · One case of VDPV-type 1 was detected from environmental sewage sample collected from the Shyamlal Lane ES site in Kolkata on 25 April 2022.
  84. [84]
    [PDF] s for urveillance Guide Poliomyelit Guidelines for Poliomyelitis ...
    Jan 5, 2025 · Achieving and maintaining high routine coverage with at least 3 doses of oral polio ... Poliovirus in Differential Risk Areas of India: India ...
  85. [85]
    Keeping India polio-free at Maha Kumbh
    Feb 6, 2025 · Under environmental surveillance for polio, sewage runoff is tested to isolate wild poliovirus and VDPV that are shed in the stool of infected ...
  86. [86]
    [PDF] Highlights of New Wild Poliovirus and cVDPV Positives Reported ...
    Aug 6, 2025 · 2025 to 05 Aug. 2025. Endemic country (WPV1). WPV1 cases (latest onset). Pakistan. 14. 14-Jul-25. Afghanistan. 1. 09-Mar-25. cVDPV2 cases ( ...
  87. [87]
    The Globally Synchronized Switch—Another Milestone Toward ...
    The switch is one more milestone on the road toward achieving certification of global polio eradication.Missing: Pulse rounds
  88. [88]
    Poliomyelitis (Polio) - Immunization, Vaccines and Biologicals
    Trivalent oral polio vaccine (tOPV) – protects against poliovirus types 1, 2, and 3 - following the "OPV Switch" in April 2016, tOPV is no longer in use ...
  89. [89]
    Polio endgame: the global switch from tOPV to bOPV - PubMed
    Type 2 OPV will be withdrawn through a globally synchronized "switch" from trivalent OPV (all three types) to bivalent OPV (types 1 and 3).
  90. [90]
    Introduction of Inactivated Poliovirus Vaccine and Switch from ... - CDC
    Jul 3, 2015 · The synchronized global switch from tOPV to bOPV will affect both the routine immunization delivery systems and the supplemental immunization ...Missing: shift supplementary
  91. [91]
    India Introduces the Inactivated Polio Vaccine - GPEI
    Dec 21, 2015 · The Government of India is introducing one dose of IPV into its routine immunization program alongside the oral polio vaccine.
  92. [92]
    India introduces Inactivated Polio Vaccine (IPV) to strengthen ...
    Jul 12, 2017 · Introduction of Inactivated Polio Vaccine (IPV) in the routine immunization programme of India is a landmark step to provide double protection to children.
  93. [93]
    Balancing Routine and Pandemic: The Synergy of India's Universal ...
    Nov 28, 2023 · Since 2014, India has expanded the basket of vaccines provided under the UIP by introducing six new vaccines—inactivated polio vaccine (IPV), ...
  94. [94]
    [PDF] Polio Eradication Efforts in India - National Health Mission
    India reported its last polio case from district Howrah, West Bengal on 13th January,. 2011. 3. WHO on 24th February 2012 removed India from the list of “ ...<|separator|>
  95. [95]
    [PDF] Comprehensive Multi-Year Plan Universal Immunization Programme
    The new vaccine introduction or scale up of a vaccine requires capacity building of health workers about dosage, route and site of administration, and ...<|separator|>
  96. [96]
    Diphtheria-tetanus-pertussis (DTP3) immunization coverage among ...
    Diphtheria-tetanus-pertussis (DTP3) immunization coverage among 1 year olds (%). Official estimate updated 15 July 2025. Focus DTP3.Missing: routine | Show results with:routine
  97. [97]
    Trends in DTP3 Vaccination in Asia (2012–2023) - PMC
    Although DTP immunization coverage is high, India ... Pakistan also exhibits substantial subnational disparities in routine immunization, including DTP3 coverage.
  98. [98]
    [PDF] Evaluation of the 2016 switch from tOPV to bOPV
    Nov 6, 2024 · In order to achieve global polio eradica-on, poliovirus must be removed from popula-ons everywhere, including the Sabin viruses contained in the ...
  99. [99]
    The Estimated Health and Economic Benefits of Three Decades of ...
    We estimate that India averted 3.94 million paralytic cases of polio, 393,918 related deaths, 1.48 billion DALYs, and gained $1.71 trillion (INR 76.91 trillion ...
  100. [100]
    [PDF] The Estimated Health and Economic Benefits of Three Decades of ...
    Aug 15, 2016 · The marked decrease in polio incidence in India was due to the Indian government's commitment to polio eradication, with close to $2 billion ( ...
  101. [101]
    Intensified pulse polio immunization: time spent and cost incurred at ...
    Total person-hours consumed were 4446 and the total direct cost was Rs 24.2 per child vaccinated during a single round of the intensified pulse polio ...
  102. [102]
    India's Last Battle in the War Against Polio - Indian Pediatrics
    In 1999, overall risk in India was estimated to be 1 case per 4.6 million OPV doses. The risk of first-dose recipient VAPP (1 case per 2.8 million doses) ...
  103. [103]
    Post-polio eradication: vaccination strategies and options for India
    Nov 12, 2014 · India could expect 1 vaccine-associated paralytic polio per 4.2-4.6 million doses of OPV. Considering the threat of vaccine-derived viruses to ...
  104. [104]
    The threat of vaccine associated poliomyelitis in India
    May 8, 2010 · In 1978 the Government of India decided to use oral polio vaccine (OPV). VAPP? In 1999, there were 181 cases of. VAPP among children under five ...<|separator|>
  105. [105]
    Advances and challenges in poliomyelitis vaccines - Frontiers
    One of the critical strategies that contributed to India's success was the implementation of extensive pulse polio vaccination campaigns. These campaigns ...
  106. [106]
    Polio switch strategy: An obituary in the making? - PMC - NIH
    May 1, 2025 · The aim is to replace the OPV with injectable polio vaccine. The Polio Eradication and Endgame Strategic Plan 2013–2018 has been made to ...
  107. [107]
    Polio programme: let us declare victory and move on
    Apr 1, 2012 · Furthermore, while India has been polio-free for a year, there has been a huge increase in non-polio acute flaccid paralysis (NPAFP). In 2011, ...
  108. [108]
    Outcome of ICMR–WHO Collaborative Study Phase-I - PMC - NIH
    Jul 6, 2023 · The long-term excretion of iVDPVs by PID patients can jeopardize polio eradication efforts. Therefore, GPEI has proposed integrating ...
  109. [109]
    India's polio-free status a cruel joke - Down To Earth
    Mar 26, 2014 · Studies have shown that death rates in children with NPAFP are twice as high as the death rate among children with polio paralysis. They ...
  110. [110]
    The impact of the national polio immunization campaign on levels ...
    During the study period, a greater increase was observed in the coverage of first dose of polio compared to three doses of polio. Moderate improvements in at ...Missing: early | Show results with:early
  111. [111]
    Doctors question India's polio strategy after surge in number of cases
    Eight states have confirmed polio cases, but most have been clustered around the district of Moradabad in the northern state of Uttar Pradesh. Health officials ...<|separator|>